A detailed history of Man Group PLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Man Group PLC holds 71,987 shares of CLPT stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,987
Holding current value
$1.2 Million
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$10.74 - $16.68 $773,140 - $1.2 Million
71,987 New
71,987 $1.11 Million
Q1 2023

May 15, 2023

SELL
$7.33 - $10.63 $1,392 - $2,019
-190 Reduced 1.26%
14,934 $126,000
Q4 2022

Feb 14, 2023

BUY
$7.7 - $11.21 $116,454 - $169,540
15,124 New
15,124 $128,000
Q2 2022

Aug 15, 2022

SELL
$7.09 - $13.65 $170,209 - $327,695
-24,007 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.8 - $11.6 $187,254 - $278,481
24,007 New
24,007 $250,000

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $409M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.